• Publications
  • Influence
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.
IMPORTANCE Understanding the major health problems in the United States and how they are changing over time is critical for informing national health policy. OBJECTIVES To measure the burden ofExpand
  • 1,574
  • 44
Health Effects of Energy Drinks on Children, Adolescents, and Young Adults
OBJECTIVE: To review the effects, adverse consequences, and extent of energy drink consumption among children, adolescents, and young adults. METHODS: We searched PubMed and Google using “energyExpand
  • 601
  • 44
Incidence, causes, and outcomes of dilated cardiomyopathy in children.
CONTEXT Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy and cause of cardiac transplantation in children. However, the epidemiology and clinical course of DCM in children areExpand
  • 687
  • 40
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.
BACKGROUND Cardiotoxicity is a recognized complication of doxorubicin therapy, but the long-term effects of doxorubicin are not well documented. We therefore assessed the cardiac status of 115Expand
  • 1,010
  • 26
Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
PURPOSE Cardiovascular status was assessed in 48 Hodgkin's disease (HD) survivors at a median of 14.3 years (range, 5.9 to 27.5 years) after diagnosis because they may be at increased risk forExpand
  • 414
  • 18
The incidence of pediatric cardiomyopathy in two regions of the United States.
BACKGROUND Population-based data on the incidence of pediatric cardiomyopathy are rare because of the lack of large, prospective studies. METHODS Since 1996 the Pediatric Cardiomyopathy RegistryExpand
  • 428
  • 17
Anthracycline cardiotoxicity: from bench to bedside.
Anthracyclines remain among the most widely prescribed and effective anticancer agents. Unfortunately, life-threatening cardiotoxicity continues to compromise their usefulness. Despite more than fourExpand
  • 364
  • 17
Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.
BACKGROUND Late cardiotoxic effects of doxorubicin are increasingly a problem for patients who survive childhood cancer. Cardiotoxicity is often progressive, and some patients have disablingExpand
  • 587
  • 15
Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.
PURPOSE To determine the incidence of clinical cardiotoxicity from anthracycline chemotherapy in children with cancer and to identify associated risk factors. PATIENTS AND METHODS The studyExpand
  • 388
  • 15
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
PURPOSE Cross-sectional studies show that cardiac abnormalities are common in long-term survivors of doxorubicin-treated childhood malignancies. Longitudinal data, however, are rare. METHODS SerialExpand
  • 513
  • 15